キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/07/26 | 3,270 | 3,275 | 3,240 | 3,250 | -5 | -0.2% | 32,600 |
2024/07/25 | 3,250 | 3,285 | 3,235 | 3,255 | -30 | -0.9% | 81,900 |
2024/07/24 | 3,280 | 3,305 | 3,275 | 3,285 | +5 | +0.2% | 43,700 |
2024/07/23 | 3,265 | 3,285 | 3,255 | 3,280 | +40 | +1.2% | 36,600 |
2024/07/22 | 3,310 | 3,310 | 3,240 | 3,240 | -40 | -1.2% | 30,000 |
2024/07/19 | 3,320 | 3,320 | 3,265 | 3,280 | -40 | -1.2% | 21,200 |
2024/07/18 | 3,275 | 3,345 | 3,245 | 3,320 | +45 | +1.4% | 94,200 |
2024/07/17 | 3,260 | 3,290 | 3,245 | 3,275 | +15 | +0.5% | 52,600 |
2024/07/16 | 3,255 | 3,260 | 3,235 | 3,260 | +5 | +0.2% | 51,200 |
2024/07/12 | 3,200 | 3,260 | 3,200 | 3,255 | +5 | +0.2% | 60,600 |
2024/07/11 | 3,225 | 3,255 | 3,220 | 3,250 | +30 | +0.9% | 70,900 |
2024/07/10 | 3,230 | 3,230 | 3,200 | 3,220 | -10 | -0.3% | 43,700 |
2024/07/09 | 3,230 | 3,235 | 3,190 | 3,230 | +30 | +0.9% | 60,400 |
2024/07/08 | 3,190 | 3,225 | 3,190 | 3,200 | +10 | +0.3% | 48,100 |
2024/07/05 | 3,215 | 3,220 | 3,190 | 3,190 | -30 | -0.9% | 39,500 |
2024/07/04 | 3,245 | 3,260 | 3,200 | 3,220 | -10 | -0.3% | 43,600 |
2024/07/03 | 3,205 | 3,230 | 3,205 | 3,230 | +5 | +0.2% | 34,700 |
2024/07/02 | 3,215 | 3,235 | 3,205 | 3,225 | -5 | -0.2% | 61,900 |
2024/07/01 | 3,270 | 3,275 | 3,225 | 3,230 | -30 | -0.9% | 63,200 |
2024/06/28 | 3,240 | 3,260 | 3,230 | 3,260 | +15 | +0.5% | 66,700 |
2024/06/27 | 3,220 | 3,245 | 3,195 | 3,245 | ±0 | ±0% | 59,000 |
2024/06/26 | 3,220 | 3,245 | 3,210 | 3,245 | +20 | +0.6% | 61,000 |
2024/06/25 | 3,190 | 3,230 | 3,180 | 3,225 | +60 | +1.9% | 72,900 |
2024/06/24 | 3,185 | 3,185 | 3,135 | 3,165 | -10 | -0.3% | 71,100 |
2024/06/21 | 3,195 | 3,205 | 3,165 | 3,175 | +5 | +0.2% | 86,900 |
2024/06/20 | 3,180 | 3,200 | 3,160 | 3,170 | -10 | -0.3% | 31,100 |
2024/06/19 | 3,190 | 3,195 | 3,170 | 3,180 | -5 | -0.2% | 17,800 |
2024/06/18 | 3,155 | 3,185 | 3,140 | 3,185 | +40 | +1.3% | 25,500 |
2024/06/17 | 3,110 | 3,145 | 3,075 | 3,145 | ±0 | ±0% | 37,900 |
2024/06/14 | 3,100 | 3,160 | 3,070 | 3,145 | +45 | +1.5% | 73,300 |
2024/06/13 | 3,150 | 3,150 | 3,075 | 3,100 | -50 | -1.6% | 36,800 |
2024/06/12 | 3,130 | 3,160 | 3,130 | 3,150 | -10 | -0.3% | 24,800 |
2024/06/11 | 3,230 | 3,240 | 3,150 | 3,160 | -55 | -1.7% | 35,400 |
2024/06/10 | 3,170 | 3,230 | 3,170 | 3,215 | +50 | +1.6% | 61,200 |
2024/06/07 | 3,160 | 3,175 | 3,140 | 3,165 | ±0 | ±0% | 32,200 |
2024/06/06 | 3,165 | 3,175 | 3,110 | 3,165 | +5 | +0.2% | 70,800 |
2024/06/05 | 3,125 | 3,165 | 3,120 | 3,160 | -35 | -1.1% | 51,400 |
2024/06/04 | 3,205 | 3,240 | 3,190 | 3,195 | -5 | -0.2% | 71,600 |
2024/06/03 | 3,165 | 3,215 | 3,155 | 3,200 | +55 | +1.7% | 92,100 |
2024/05/31 | 3,065 | 3,150 | 3,065 | 3,145 | +95 | +3.1% | 208,200 |
2024/05/30 | 3,010 | 3,070 | 3,000 | 3,050 | +15 | +0.5% | 116,500 |
2024/05/29 | 3,055 | 3,070 | 3,020 | 3,035 | -20 | -0.7% | 63,300 |
2024/05/28 | 3,130 | 3,130 | 3,055 | 3,055 | -80 | -2.6% | 92,700 |
2024/05/27 | 3,190 | 3,190 | 3,120 | 3,135 | -70 | -2.2% | 109,100 |
2024/05/24 | 3,150 | 3,220 | 3,150 | 3,205 | +55 | +1.7% | 138,000 |
2024/05/23 | 3,090 | 3,155 | 3,090 | 3,150 | +80 | +2.6% | 65,400 |
2024/05/22 | 3,130 | 3,155 | 3,070 | 3,070 | -55 | -1.8% | 59,800 |
2024/05/21 | 3,165 | 3,175 | 3,125 | 3,125 | -35 | -1.1% | 58,800 |
2024/05/20 | 3,140 | 3,180 | 3,140 | 3,160 | ±0 | ±0% | 61,300 |
2024/05/17 | 3,140 | 3,170 | 3,110 | 3,160 | +20 | +0.6% | 47,200 |
1~
50
件表示中 / 3506件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 325,000円 | +9.8% | -12.1% | 2.77% | 12.71倍 | 0.65倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 406,500円 | +4.2% | -21.6% | 3.69% | 27.49倍 | 1.07倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
住友ファーマ | 41,100円 | +7.5% | - | 0.00% | - | 1.05倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
東和薬品 | 299,500円 | +14.7% | -28.1% | 2.00% | 12.71倍 | 0.95倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ネクセラファーマ | 169,000円 | +150.7% | - | 0.00% | 43.41倍 | 2.27倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム